Clinical OMICS

NOV-DEC 2018

Healthcare magazine for research scientists, labs, pathologists, hospitals, cancer centers, physicians and biopharma companies providing news articles, expert interviews and videos about molecular diagnostics in precision medicine

Issue link:

Contents of this Issue


Page 40 of 51 November/December 2018 Clinical OMICs 39 New Products Online Tool for Easy Custom NGS Assay Design Paragon Genomics has launched ParagonDesigner, a web-based tool that enables rapid design of CleanPlex Custom NGS Panels. The on- line portal features a streamlined, user-friendly interface that simplifies the assay design process, allowing researchers to build custom- ized next-generation sequencing (NGS) assays for their specific needs. With ParagonDesigner, users define the content of their custom NGS assays by submitting their targets online. The tool features a database of more than 1,300 pre-designed, clinically relevant human genes, allowing CleanPlex Custom NGS Panels to be assembled for most applications. The design tool also issues a report on the estimat- ed panel size and design coverage for review prior to submission. Panel design experts are available to provide support to all customers. The company delivers custom NGS panels in 2 to 4 weeks. Paragon Genomics Comprehensive Sample Type Coverage for HSV Testing DiaSorin Molecular recently received FDA clearance extending the sample type claims of its Simplexa HSV 1 & 2 Direct assay, expanding the type of samples that can be tested to include genital swabs and all cutaneous and mucocutaneous swab samples. With these additional sample types, the assay now has comprehensive sample type coverage for HSV. The Simplexa HSV 1 & 2 Direct kit real-time PCR assay is intended for the in vitro qualita- tive detection and differentiation of HSV-1 and HSV-2 DNA in cerebrospinal fluid (CSF) and swab samples. The test does not require a DNA extraction step and processes up to eight samples per run in about one hour. Rapid detection of HSV infection through molecular testing can be critical to decision-making for life-saving therapeutics. The coverage of multiple sample types in a moderate complexity assay enables laboratories to easily manage various HSV testing needs with one test. DiaSorin Molecular Myeloid DNA Reference Standard for Leukemia Testing Gene editing and gene modulation technology company Horizon Dis- covery Group has launched a new Myeloid DNA Reference Standard. This large cell-line derived myeloid cancer reference standard enables faster, more reliable, and more cost-effective assay validation, to sup- port the market in bringing routine testing into practice. The cell line– derived reference standard contains 22 mutations across 19 genes that are commonly associated with myeloid cancer. This provides genetic testing laboratories and assay developers with a tool to effectively validate and optimize myeloid genetic tests with DNA of known genotype which closely mimics the genomic DNA format and mutations present in real patient samples. The Myeloid DNA Reference Standard contains variants in more genes than most clinical material, enabling quality assurance goals can be reached faster. Horizon Discovery Group Cyto-Mine Studio Software Suite Sphere Fluidics, a company specializing in single-cell analysis systems enabled by its patented picodrop- let technology has introduced Cyto-Mine Studio Software Suite, software for its Cyto-Mine Single Cell Analysis System. Cyto-Mine is an automated plat- form which integrates single-cell screening, sorting, isolation and clone verification. The Cyto-Mine Stu- dio Software Suite has updated features and user interfaces for the Cyto-Mine Instrument Control Software and the off-line Cyto-Mine Data Analysis Software. It has an application programming inter- face (API) that enables easy communication with many industry-standard robotic platforms and links to corporate databases for easy data transfer, and includes features such as single-cell dispensing to individual wells of 96- and 384-well microtiter plates and software data outputs from single cell imaging analysis. Sphere Fluidics

Articles in this issue

Links on this page

Archives of this issue

view archives of Clinical OMICS - NOV-DEC 2018